ANTIBODIES SPECIFIC TO MMP9 Russian patent published in 2020 - IPC C07K16/40 C12N15/13 C12N15/63 G01N33/573 A61K39/395 A61P35/00 A61P37/00 

Abstract RU 2714043 C2

FIELD: biotechnology.

SUBSTANCE: present invention refers to immunology and biotechnology. Disclosed are novel embodiments of antibodies or antigen-binding fragments thereof, which specifically bind to MMP9 and contain variable regions of heavy and light chains, each of which is characterized by the presence of at least corresponding CDRs1-3. Described are: a coding antibody or its antigen-binding nucleic acid fragment, a recombinant expression vector thereof, a host cell carrying such a vector, and a method for producing an antibody using such a cell. Disclosed are an antibody-based pharmaceutical composition, as well as use of an antibody for preventing and/or treating MMP9-associated diseases. Also disclosed is a method for detecting the presence and/or concentration of the MMP9 protein ex vivo in a biological antibody-based sample, wherein the signal intensity correlates with the MMP-9 protein concentration in the sample.

EFFECT: use of the invention provides antibodies which are capable of neutralizing MMP9 activity, which can find application in preventing and/or treating inflammatory, autoimmune diseases and/or cancers associated with MMP9.

26 cl, 16 dwg, 8 tbl, 12 ex

Similar patents RU2714043C2

Title Year Author Number
PROTEASE-ACTIVATED T-CELL BINDING BISPECIFIC MOLECULES 2017
  • Bryunker Peter
  • Krosdejl-Vud Rebekka
  • Klyajn Kristian
  • Shantser Jyurgen Mikhael
  • Shtubenraukh Kaj-Gunnar
  • Umana Pablo
  • Gajger Martina
  • Sallivan Erik
  • Patel Dzhigar
RU2830288C2
ANTI-CLDN-18.2 ANTIBODY AND USE THEREOF 2021
  • Zhou, Yuehua
  • Zhang, Jing
  • Liu, Hui
  • Liu, Hongchuan
  • Wu, Hai
  • Yao, Jian
  • Huang, Lanqing
RU2829997C1
CD40 LIGAND THERAPEUTIC ANTIBODIES 2018
  • Lugovskoy, Alexey
RU2770209C2
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMOR 2017
  • Okano, Fumiesi
  • Saito, Takanori
RU2766586C2
ANTIBODIES AGAINST SIGNAL-REGULATORY ALPHA PROTEIN AND THEIR APPLICATION METHODS 2017
  • Pons, Jaume
  • Sim, Bang Janet
  • Wan, Hong
  • Kuo, Tracy Chia-Chien
  • Kauder, Steven Elliot
  • Harriman, William Don
  • Izquierdo, Shelley
RU2771964C2
BISPECIFIC ANTIBODY AGAINST RABIES VIRUS AND ITS APPLICATION 2019
  • Liu Zhigang
  • Hao Xiaobo
  • Liu Yulan
  • Guo Jingjing
RU2764740C1
MULTI-SPECIFIC ANTIGEN-BINDING MOLECULE HAVING SUBSTITUTE FUNCTIONAL ACTIVITY OF BLOOD COAGULATING FACTOR VIII CO-FACTOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SPECIFIED MOLECULE AS ACTIVE INGREDIENT 2018
  • Teranishi Yuri
  • Kato Kazuki
  • Koga Hikaru
  • Igawa Tomoyuki
  • Yamaguchi Kazuki
  • Soeda Tetsuhiro
RU2812909C2
ANTIBODIES TARGETING BONE 2018
  • Qiu, Huawei
  • Park, Sunghae
  • Stefano, James
RU2801206C2
BISPECIFIC FUSION PROTEIN AND ITS USE 2021
  • Fang, Jianmin
RU2801528C2
ANTIBODY CAPABLE OF BINDING TO THYMIC STROMAL LYMPHOPOIETIN, AND USE THEREOF 2020
  • Shi Tszinpin
  • In Khua
  • Li Tintin
  • Van Ifan
  • Yan Gujmej
  • Ge Khu
  • Tao Vejkan
RU2825304C2

RU 2 714 043 C2

Authors

Chvatchko Missotten Ioland

Goffen Lorans

Lezher Olive

Dann Stiven M.

Pauer Kristin

Mondrel Kinsi

Dates

2020-02-11Published

2015-08-13Filed